WARF TECHNOLOGIES

The present disclosure relates to vims-like particles and vaccine compositions for inducing immunity and preventing respiratory syncytial vims (RSV) infection. Specifically, the disclosure provides vims like-particles (VLPs) for use in inducing immu­nity to respiratory syncyhial vims (RSV) infections or symptoms thereof, wherein the VLP comprising a respiratory RSV matrix protein (M) and an RSV M2- l protein, a glycoprotein (G), a fusion protein (F), and/or a phosphoprotein (P).

For More Information About the Inventors

• Elizabeth Wright

Tech Fields

• Therapeutics & Vaccines : Vaccines